CGS : Biotech & Pharma

Biotech & Pharma : Displaying 744-753 of 1029

Entrepreneur Puts Himself Up for Study In Genetic 'Tell-All'by ANTONIO REGALADO, Wall Street JournalOctober 18th, 2006"Dr. Venter says his project will yield the first complete map of an individual human."

Hope, unfulfilled promises on stem cell workby Sally Lehrman, Boston GlobeOctober 1st, 2006"Scientists in many fields have sometimes exaggerated the importance of their work. But stem cell researchers seem uniquely inclined toward dramatic claims."

Fake it Til You Make itGenetic CrossroadsSeptember 14th, 2006Advanced Cell Technology is a small biotech company with a knack for generating media headlines, which in turn, generate controversy, money from investors and stock spikes, but little in the way of real scientific advance. Last month, ACT—now a publicly traded company—did it again.

Opinion: Slippery slope: Inflated science claims equal $$by By Robert Bazell, MSNBCAugust 29th, 2006"The campaign to generate hype kicked off weeks before the news broke _ as often happens when biotechnology firms claim major achievements"

Critic Alleges Deceit in Study On Stem Cellsby Rick Weiss, Washington PostAugust 26th, 2006"A landmark scientific report that was supposed to bridge the gap between proponents and opponents of human embryonic stem cell research has become the focus of an escalating feud..."

Book reviews: Stem cells, enhancement and cloningGenetic CrossroadsAugust 4th, 2006Genetic Crossroads reviews Stem Cell Wars (Eve Herold), Challenging Nature: The Clash of Science and Spirituality at the New Frontiers of Life (Lee M. Silver), and After Dolly: The Uses and Misuses of Human Cloning (Ian Wilmut and Roger Highfield)

When is the Racial Pharmacy Bad Medicine?by Osagie Obasogie and David Winickoff, Bioethics ForumJuly 19th, 2006"The central concern here is as much about how people think about race and racial disparities as it is about particular health outcomes."

How a University's Patents May Limit Stem-Cell Researchby By ANTONIO REGALADO and DAVID P. HAMILTON, Wall Street JournalJuly 18th, 2006"But some government officials and scientists say the strict limits imposed by the Bush administration are only part of what's hindering stem-cell research. Another problem: several broad patents held by a University of Wisconsin foundation."

Panel scraps stem cell discovery-sharing ruleby Sandy Kleffman, Contra Costa TimesJuly 15th, 2006"A panel deciding what benefits California taxpayers will receive from their $3 billion investment in stem cell research agreed Friday to remove a discovery-sharing requirement that the biotech industry vigorously opposed."

Biotech execs: No sharing of stem-cell researchby Steve Johnson, San Jose Mercury NewsJune 30th, 2006"A proposal that would let the state share in any profits that result from its $3 billion stem-cell research grants and force researchers to freely disseminate their discoveries has riled biotech executives..."

Displaying 744-753 of 1029
< Prev Next >>
« First Page Last Page »
« Show Complete List »

[ more + ]

ESPAÑOL | PORTUGUÊS | Русский